Table 1:
Patients demographics and tumor characteristics.
| Age – Years | Race | |||||
|---|---|---|---|---|---|---|
| Mean | 54 | Caucasian | 51 (50%) | |||
| Median | 54 | African-American | 48 (48%) | |||
| Range | 29 – 86 | Other | 2 (2%) | |||
| *Tumor Size (cm)-at initial Diagnosis | * Hormone Receptor/Her-2 status | |||||
| T1 | 19 (19%) | Caucasian | African-Am | Other | Total | |
| T2 | 15 (14%) | ER+ | 31 (61%) | 27 (56%) | 2 (100%) | 60 (59%) |
| T3 | 19 (19%) | PR+ | 19 (37%) | 25 (52%) | 0 (0%) | 44 (44%) |
| T4 | 0 (0%) | ER+PR+ | 18 (35%) | 24 (50%) | 0 (0%) | 42 (42%) |
| Unknown | 48 (48%) | ER−PR− | 19 (37%) | 24 (50%) | 0 (0%) | 43 (43%) |
| ER or PR Unknown | 3 (3%) | 0 (0%) | 0 (0%) | 3 (3%) | ||
| *Axillary Lymph Node-at initial diagnosis | Her-2 Positive | 30 (59%) | 35 (73%) | 2 (100%) | 67 (66%) | |
| Positive | 40 (40%) | Her-2 Negative | 15 (29%) | 11 (23%) | 0 (0%) | 26 (26%) |
| Negative | 21 (20%) | Her-2 Unknown | 6 (12%) | 2 (4%) | 0 (0%) | 8 (8%) |
| Unknown | 40 (40%) | Triple Negative | 6 (6%) | 13 (13%) | 0 (0%) | 19 (19%) |
| Metastatic sites | ||||||
| Visceral | 14 (14%) | ≤2 Sites | 59 (58%) | |||
| Non-Visceral | 29 (30%) | >2 Sites | 42 (42%) | |||
| Both | 57 (56%) | NOTE: * indicates at Primary Diagnosis | ||||
*
Tumor size and Axillary lymph node (LN) status of patients were determined at initial diagnosis of breast cancer. All other parameters were determined at study entry. Visceral metastatic sites correspond to lung, liver, and organs of digestive, excretory, reproductive, and circulatory systems.